Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/327
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorWOLOSKER, Nelson-
dc.contributor.authorCAMPOS, Jose Ribas Milanez de-
dc.contributor.authorKAUFFMAN, Paulo-
dc.contributor.authorPUECH-LEAO, Pedro-
dc.date.accessioned2013-07-30T14:39:03Z-
dc.date.available2013-07-30T14:39:03Z-
dc.date.issued2012-
dc.identifier.citationJOURNAL OF VASCULAR SURGERY, v.55, n.6, p.1696-1700, 2012-
dc.identifier.issn0741-5214-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/327-
dc.description.abstractIntroduction: Video-assisted thoracic sympathectomy provides excellent resolution of palmar and axillary hyperhidrosis but is associated with compensatory hyperhidrosis. Low doses of oxybutynin, an anticholinergic medication that competitively antagonizes the muscarinic acetylcholine receptor, can be used to treat palmar hyperhidrosis with fewer side effects. Objective: This study evaluated the effectiveness and patient satisfaction of oral oxybutynin at low doses (5 mg twice daily) compared with placebo for treating palmar hyperhidrosis. Methods: This was prospective, randomized, and controlled study. From December 2010 to February 2011, 50 consecutive patients with palmar hyperhidrosis were treated with oxybutynin or placebo. Data were collected from 50 patients, but 5 (10.0%) were lost to follow-up. During the first week, patients received 2.5 mg of oxybutynin once daily in the evening. From days 8 to 21, they received 2.5 mg twice daily, and from day 22 to the end of week 6, they received 5 mg twice daily. All patients underwent two evaluations, before and after (6 weeks) the oxybutynin treatment, using a clinical questionnaire and a clinical protocol for quality of life. Results: Palmar and axillary hyperhidrosis improved in >70% of the patients, and 47.8% of those presented great improvement. Plantar hyperhidrosis improved in >90% of the patients. Most patients (65.2%) showed improvements in their quality of life. The side effects were minor, with dry mouth being the most frequent (47.8%). Conclusions: Treatment of palmar and axillary hyperhidrosis with oxybutynin is a good initial alternative for treatment given that it presents good results and improves quality of life. (J Vasc Surg 2012;55:1696-700.)-
dc.language.isoeng-
dc.publisherMOSBY-ELSEVIER-
dc.relation.ispartofJournal of Vascular Surgery-
dc.rightsrestrictedAccess-
dc.subject.otherquality-of-life-
dc.subject.otherendoscopic thoracic sympathectomy-
dc.subject.otherthoracoscopic sympathectomy-
dc.subject.othermanagement-
dc.subject.otherimpact-
dc.subject.otherlevel-
dc.titleA randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis-
dc.typearticle-
dc.rights.holderCopyright MOSBY-ELSEVIER-
dc.identifier.doi10.1016/j.jvs.2011.12.039-
dc.identifier.pmid22341836-
dc.subject.wosSurgery-
dc.subject.wosPeripheral Vascular Disease-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage1696-
hcfmusp.description.endpage1700-
hcfmusp.description.issue6-
hcfmusp.description.volume55-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84861229980-
hcfmusp.origem.idWOS:000304206000021-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAmir M, 2000, ISRAEL J PSYCHIAT, V37, P25-
hcfmusp.relation.referenceAraujo Carlos Alberto Almeida de, 2009, J Bras Pneumol, V35, P213-
hcfmusp.relation.referenceArisco AM, 2009, DRUG DES DEV THER, V3, P151-
hcfmusp.relation.referenceBaumgartner FJ, 2009, ANN VASC SURG, V23, P1, DOI 10.1016/j.avsg.2008.04.014-
hcfmusp.relation.referenceCerfolio RJ, 2011, ANN THORAC SURG, V91, P1642, DOI 10.1016/j.athoracsur.2011.01.105-
hcfmusp.relation.referencede Campos JRM, 2003, ANN THORAC SURG, V76, P886-
hcfmusp.relation.referencede Campos JRM, 2005, CLIN AUTON RES, V15, P116, DOI 10.1007/s10286-005-0259-6-
hcfmusp.relation.referenceGelbard CM, 2008, PEDIATR DERMATOL, V25, P591, DOI 10.1111/j.1525-1470.2008.00782.x-
hcfmusp.relation.referenceIshy A, 2011, INTERACT CARDIOV TH, V12, P545, DOI 10.1510/icvts.2010.252015-
hcfmusp.relation.referenceKopelman D, 2008, WORLD J SURG, V32, P2343, DOI 10.1007/s00268-008-9716-4-
hcfmusp.relation.referenceLau W T, 2001, Hawaii Med J, V60, P137-
hcfmusp.relation.referenceLefrandt JD, 2007, NETH J MED, V65, P356-
hcfmusp.relation.referenceLin TS, 1999, SURG NEUROL, V52, P453, DOI 10.1016/S0090-3019(99)00111-1-
hcfmusp.relation.referenceMijnhout GS, 2006, NETH J MED, V64, P326-
hcfmusp.relation.referenceNabi G, 2006, COCHRANE DB SYST REV, V18-
hcfmusp.relation.referenceOjimba TA, 2004, BRIT J SURG, V91, P264, DOI 10.1002/bjs.4511-
hcfmusp.relation.referenceRibas Milanez CJ, 2006, J LAPAROENDOSC ADV A, V16, P598-
hcfmusp.relation.referenceSAYEED RA, 1998, EUR J SURG S, V580, P39-
hcfmusp.relation.referenceSchmidt J, 2006, ANN THORAC SURG, V81, P1048, DOI 10.1016/j.athoracsur.2005.09.046-
hcfmusp.relation.referenceSchollhammer M, 2007, ARCH DERMATOL, V143, P544, DOI 10.1001/archderm.143.4.544-
hcfmusp.relation.referenceStrutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040-
hcfmusp.relation.referenceTupker RA, 2006, ARCH DERMATOL, V142, P1065, DOI 10.1001/archderm.142.8.1065-
hcfmusp.relation.referenceVorkamp T, 2010, SURG-J R COLL SURG E, V8, P287, DOI 10.1016/j.surge.2010.06.002-
hcfmusp.relation.referenceWeber A, 2005, BRIT J DERMATOL, V152, P342, DOI 10.1111/J.1365-2133.2004.06334.X-
hcfmusp.relation.referenceWolosker N, 2008, J LAPAROENDOSC ADV S, V18, P102, DOI 10.1089/lap.2007.0030-
hcfmusp.relation.referenceWolosker N, 2011, ANN VASC SURG, V25, P1057, DOI 10.1016/j.avsg.2011.06.007-
hcfmusp.relation.referenceWolosker N, 2011, CLIN AUTON RES, V21, P389, DOI 10.1007/s10286-011-0128-4-
hcfmusp.relation.referenceWolosker N, 2011, AN BRAS DERMATOL, V86, P235-
hcfmusp.relation.referenceWolosker N, 2007, CLIN AUTON RES, V17, P172, DOI 10.1007/s10286-007-0420-5-
dc.description.indexMEDLINE-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus74-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCG
Departamento de Cirurgia - FM/MCG

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/28
LIM/28 - Laboratório de Cirurgia Vascular e da Cabeça e Pescoço

Artigos e Materiais de Revistas Científicas - LIM/61
LIM/61 - Laboratório de Pesquisa em Cirurgia Torácica


Files in This Item:
File Description SizeFormat 
art_WOLOSKER_A_randomized_placebo_controlled_trial_of_oxybutynin_for_2012_eng.pdf
  Restricted Access
publishedVersion (English)152.2 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.